Last 7 days
-18.4%
Last 30 days
-20.9%
Last 90 days
-58.9%
Trailing 12 Months
-90.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-18 | Dulac Edward J III | sold | -13,210 | 2.8 | -4,718 | chief financial officer |
2023-08-04 | Xu Yuan | sold | -2,344 | 3.71 | -632 | - |
2023-07-05 | Dulac Edward J III | sold | -25,029 | 4.83 | -5,182 | chief financial officer |
2023-07-05 | Powl Brian T. | sold | -18,769 | 4.87 | -3,854 | chief commercial officer |
2023-06-14 | Xu Yuan | sold | -19,306 | 5.58 | -3,460 | - |
2023-04-21 | Redmile Group, LLC | bought | 1,586,030 | 6.18 | 256,639 | - |
2023-04-20 | Redmile Group, LLC | bought | 119,800 | 5.99 | 20,000 | - |
2023-04-18 | Chu Yu-Waye | sold | -16,647 | 6.57491 | -2,532 | chief medical officer |
2023-04-14 | Redmile Group, LLC | sold | -32,075,500 | 5.84 | -5,492,380 | - |
2023-04-14 | Redmile Group, LLC | bought | 154,200 | 6.00 | 25,700 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | reduced | -4.34 | -574,000 | 2,281,000 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 86.67 | 57,336 | 159,936 | -% |
2023-08-22 | Asset Dedication, LLC | unchanged | - | - | - | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -1.94 | -102,416 | 462,996 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -3.34 | -7,063 | 30,257 | -% |
2023-08-17 | Coppell Advisory Solutions LLC | new | - | 42,375 | 42,375 | 0.01% |
2023-08-16 | Nuveen Asset Management, LLC | added | 30.89 | 116,312 | 1,374,310 | -% |
2023-08-15 | COLONY GROUP LLC | unchanged | - | -22,000 | 114,000 | -% |
2023-08-15 | BENJAMIN F. EDWARDS & COMPANY, INC. | unchanged | - | -1,000 | 2,000 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 24.88 | 24,879 | 605,139 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 10, 2023 | state street corp | 14.24% | 13,989,432 | SC 13G/A | |
Apr 19, 2023 | redmile group, llc | 14.9% | 15,071,096 | SC 13D/A | |
Mar 22, 2023 | millennium management llc | 1.7% | 1,696,431 | SC 13G | |
Mar 10, 2023 | vanguard group inc | 10.12% | 9,936,042 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 5.8% | 5,591,517 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 8.20% | 7,972,551 | SC 13G/A | |
Feb 03, 2023 | state street corp | 6.11% | 5,935,459 | SC 13G | |
Jan 06, 2023 | blackrock inc. | 10.0% | 9,725,895 | SC 13G/A | |
Feb 09, 2022 | ark investment management llc | 10.80% | 10,312,167 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.4% | 7,060,552 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 01, 2023 | 8-K | Current Report | |
Aug 21, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 08, 2023 | 8-K | Current Report | |
Aug 08, 2023 | 10-Q | Quarterly Report | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 144 | Notice of Insider Sale Intent | |
Jul 06, 2023 | 4 | Insider Trading | |
Jul 06, 2023 | 4 | Insider Trading | |
Jul 05, 2023 | 144 | Notice of Insider Sale Intent |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 143.9B | 26.6B | 4.09% | 19.43% | 18.04 | 5.41 | 0.75% | 21.34% |
GILD | 94.2B | 27.4B | -2.64% | 21.17% | 17.17 | 3.44 | -0.48% | 32.56% |
MRNA | 37.4B | 10.7B | -12.29% | -20.60% | 30.97 | 3.51 | -53.67% | -91.41% |
BIIB | 37.3B | 10.0B | -3.56% | 28.94% | 14.01 | 3.74 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 11.1B | 1.7B | 5.73% | 9.84% | 62.9 | 6.63 | 29.01% | 1345.90% |
BBIO | 4.3B | - | -8.76% | 177.74% | -7.34 | 48.33 | 54.84% | -12.96% |
DNLI | 3.0B | - | -4.47% | -19.12% | -23.53 | 37.44 | 122.90% | 54.78% |
BEAM | 1.8B | 80.2M | -0.86% | -51.14% | -5.62 | 22.95 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.4B | 121.2M | -17.40% | -25.98% | -4.84 | 11.47 | -70.36% | -531.73% |
REPL | 952.5M | 15.3M | -21.41% | 1.70% | -5.24 | 62.21 | 1090.59% | -36.57% |
NVAX | 670.5M | 1.6B | -9.19% | -65.19% | -1.14 | 0.42 | 23.74% | 60.24% |
FATE | 204.9M | - | -20.91% | -90.53% | -0.97 | 1.5 | 116.83% | 16.61% |
SGMO | 120.9M | - | -9.97% | -85.99% | -0.61 | 0.5 | 113.96% | -15.19% |
VXRT | 107.9M | 2.1M | -8.04% | -65.52% | -1.07 | 52.51 | 487.70% | -8.66% |
IBIO | 3.7M | - | -11.22% | -96.54% | -0.05 | 3.21 | - | -129.46% |
-6.8%
-32.9%
-62.0%
100%
98.1%
42.7%
Y-axis is the maximum loss one would have experienced if Fate Therapeutics was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -100.0% | - | 136,866,000 | 96,300,000 | 69,013,000 | 68,257,000 | 63,120,000 | 55,846,000 | 54,675,000 | 48,008,000 | 40,061,000 | 31,434,000 | 18,340,000 | 13,211,000 | 10,563,000 | 10,680,000 | 9,539,000 | 8,136,000 | 6,346,000 | 4,740,000 | 4,106,000 | 4,106,000 |
Operating Expenses | -9.6% | 361,217,000 | 399,377,000 | 404,686,000 | 382,362,000 | 349,838,000 | 308,371,000 | 272,840,000 | 235,686,000 | 205,883,000 | 179,864,000 | 159,519,000 | 142,104,000 | 132,607,000 | 125,336,000 | 111,407,000 | 97,929,000 | 86,099,000 | 79,830,000 | 71,832,000 | 66,701,000 | 60,349,000 |
S&GA Expenses | 2.7% | 87,704,000 | 85,433,000 | 84,232,000 | 79,584,000 | 73,747,000 | 65,564,000 | 57,321,000 | 50,699,000 | 43,332,000 | 38,667,000 | 33,896,000 | 30,254,000 | 28,249,000 | 26,016,000 | 23,637,000 | 21,273,000 | 19,008,000 | 17,554,000 | 15,808,000 | 14,885,000 | 13,592,000 |
R&D Expenses | -12.9% | 273,513,000 | 313,944,000 | 320,454,000 | 302,778,000 | 276,091,000 | 242,807,000 | 215,519,000 | 184,987,000 | 162,551,000 | 141,197,000 | 125,623,000 | 111,850,000 | 104,358,000 | 99,320,000 | 87,770,000 | 76,656,000 | 67,091,000 | 62,276,000 | 56,024,000 | 51,816,000 | 46,757,000 |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,752,000 | 1,644,000 | 1,673,000 | 1,689,000 | 1,696,000 | 1,678,000 | 1,627,000 |
Net Income | 9.9% | -211,599,000 | -234,949,000 | -281,721,000 | -294,046,000 | -253,754,000 | -232,782,000 | -212,151,000 | -196,617,000 | -211,993,000 | -184,932,000 | -173,387,000 | -148,578,000 | -116,503,000 | -111,909,000 | -98,149,000 | -85,874,000 | -76,047,000 | -72,223,000 | -66,598,000 | -63,068,000 | -56,970,000 |
Net Income Margin | 100.0% | - | -1.72 | -2.93 | -4.26 | -3.72 | -3.69 | -3.80 | -3.60 | -4.42 | -4.62 | -5.52 | -8.10 | -8.82 | -10.59 | -9.19 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -241,145,000 | -283,774,000 | -290,370,000 | -274,757,000 | -257,194,000 | -213,574,000 | -147,848,000 | -131,425,000 | -47,495,000 | -44,161,000 | -49,350,000 | -38,765,000 | -99,074,000 | -90,570,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -7.2% | 585 | 630 | 706 | 749 | 807 | 858 | 921 | 985 | 1,016 | 1,046 | 622 | 626 | 654 | 322 | 302 | 340 | 200 | 221 | 213 | 220 | 83.00 |
Current Assets | -10.4% | 392 | 438 | 502 | 535 | 599 | 599 | 633 | 694 | 713 | 804 | 494 | 497 | 540 | 208 | 227 | 306 | 165 | 186 | 205 | 214 | 80.00 |
Cash Equivalents | 11.4% | 47.00 | 42.00 | 61.00 | 82.00 | 55.00 | 65.00 | 134 | 129 | 77.00 | 106 | 167 | 349 | 433 | 83.00 | 100 | 250 | 71.00 | 183 | 191 | 183 | 36.00 |
Net PPE | -2.1% | 106 | 109 | 110 | 109 | 103 | 98.00 | 92.00 | 75.00 | 59.00 | 48.00 | 32.00 | 21.00 | 16.00 | 12.00 | 11.00 | 10.00 | 9.00 | 8.00 | 5.00 | 4.00 | 3.00 |
Current Liabilities | -8.1% | 45.00 | 49.00 | 114 | 104 | 92.00 | 78.00 | 81.00 | 92.00 | 106 | 95.00 | 86.00 | 54.00 | 45.00 | 25.00 | 28.00 | 41.00 | 29.00 | 29.00 | 27.00 | 23.00 | 16.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 5.00 | 4.00 | 2.00 | 3.00 | 2.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.00 | 11.00 | 12.00 | 12.00 | 13.00 |
Shareholder's Equity | -8.3% | 438 | 477 | 484 | 518 | 580 | 633 | 679 | 730 | 752 | 790 | 384 | 424 | 474 | 219 | 245 | 268 | 128 | 146 | 160 | 174 | 52.00 |
Retained Earnings | -4.9% | -1,122 | -1,069 | -1,050 | -994 | -910 | -834 | -769 | -700 | -657 | -602 | -556 | -503 | -445 | -417 | -383 | -355 | -328 | -305 | -285 | -269 | -252 |
Additional Paid-In Capital | 0.8% | 1,561 | 1,548 | 1,536 | 1,516 | 1,495 | 1,471 | 1,449 | 1,431 | 1,409 | 1,392 | 941 | 928 | 919 | 636 | 628 | 623 | 456 | 451 | 446 | 443 | 304 |
Shares Outstanding | 0.3% | 99.00 | 98.00 | 97.00 | 97.00 | 97.00 | 96.00 | 96.00 | 95.00 | 94.00 | 93.00 | 88.00 | 81.00 | 78.00 | 76.00 | 68.00 | 67.00 | 65.00 | 65.00 | 56.00 | 53.00 | 53.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 11.6% | -187 | -212 | -248 | -243 | -221 | -200 | -162 | -113 | -110 | -39.65 | -39.23 | -44.10 | -33.20 | -92.35 | -83.17 | -68.66 | -52.38 | -43.59 | -38.65 | -38.35 | -44.56 |
Share Based Compensation | -10.9% | 63.00 | 70.00 | 79.00 | 74.00 | 68.00 | 61.00 | 54.00 | 49.00 | 43.00 | 37.00 | 31.00 | 27.00 | 23.00 | 20.00 | 17.00 | 15.00 | 12.00 | 9.00 | 6.00 | 5.00 | 5.00 |
Cashflow From Investing | -3.9% | 176 | 183 | 167 | 185 | 182 | 141 | -324 | -561 | -693 | -656 | -161 | -105 | -15.14 | -142 | -157 | -30.55 | -53.56 | 52.00 | -0.46 | -3.64 | -3.28 |
Cashflow From Financing | -50.6% | 3.00 | 7.00 | 9.00 | 11.00 | 18.00 | 18.00 | 453 | 455 | 448 | 719 | 283 | 264 | 425 | 150 | 150 | 166 | 141 | 142 | 141 | 182 | 53.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Collaboration revenue | $ 933 | $ 18,549 | $ 59,913 | $ 36,963 |
Type of Revenue [Extensible List] | us-gaap:LicenseMember | us-gaap:LicenseMember | us-gaap:LicenseMember | us-gaap:LicenseMember |
Operating expenses: | ||||
Research and development | $ 40,876 | $ 81,307 | $ 106,505 | $ 153,446 |
General and administrative | 22,622 | 20,351 | 44,565 | 41,093 |
Total operating expenses | 63,498 | 101,658 | 151,070 | 194,539 |
Loss from operations | (62,565) | (83,109) | (91,157) | (157,576) |
Other income: | ||||
Interest income | 4,381 | 757 | 8,075 | 1,175 |
Change in fair value of stock price appreciation milestones | 393 | 5,881 | 2,111 | 14,240 |
Other income | 5,036 | 366 | 9,335 | 366 |
Total other income | 9,810 | 7,004 | 19,521 | 15,781 |
Net loss | (52,755) | (76,105) | (71,636) | (141,795) |
Other comprehensive income (loss): | ||||
Unrealized gain (loss) on available-for-sale securities, net | 59 | (531) | 1,267 | (2,619) |
Comprehensive loss | $ (52,696) | $ (76,636) | $ (70,369) | $ (144,414) |
Net loss per common share, basic | $ (0.54) | $ (0.79) | $ (0.73) | $ (1.47) |
Net loss per common share, diluted | $ (0.54) | $ (0.79) | $ (0.73) | $ (1.47) |
Weighted-average common shares used to compute, basic net loss per share | 98,400,355 | 96,704,413 | 98,228,476 | 96,524,968 |
Weighted-average common shares used to compute diluted net loss per share | 98,400,355 | 96,704,413 | 98,228,476 | 96,524,968 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 46,802 | $ 61,333 |
Accounts receivable | 2,833 | 38,480 |
Short-term investments and related maturity receivables | 331,133 | 374,894 |
Prepaid expenses and other current assets | 11,414 | 27,367 |
Total current assets | 392,182 | 502,074 |
Long-term investments | 7,291 | 4,942 |
Property and equipment, net | 106,331 | 110,020 |
Operating lease right-of-use assets | 63,743 | 66,069 |
Restricted cash | 15,177 | 15,227 |
Collaboration contract assets | 0 | 7,196 |
Other assets | 33 | 33 |
Total assets | 584,757 | 705,561 |
Current liabilities: | ||
Accounts payable | 7,506 | 8,265 |
Accrued expenses | 29,469 | 53,932 |
CIRM award liability, current portion | 0 | 4,000 |
Deferred revenue | 1,929 | 42,226 |
Operating lease liabilities, current portion | 5,786 | 5,628 |
Total current liabilities | 44,690 | 114,051 |
Operating lease liabilities, net of current portion | 100,562 | 103,710 |
Stock price appreciation milestones | 1,750 | 3,861 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; authorized shares-5,000,000 at June 30, 2023 and December 31, 2022; Class A Convertible Preferred shares issued and outstanding-2,761,108 at June 30, 2023 and 2,794,549 December 31, 2022 | 3 | 3 |
Common stock, $0.001 par value; authorized shares-250,000,000 at June 30, 2023 and December 31, 2022; issued and outstanding-98,522,718 at June 30, 2023 and 97,294,917 at December 31, 2022 | 99 | 97 |
Additional paid-in capital | 1,560,680 | 1,536,497 |
Accumulated other comprehensive loss | (587) | (1,854) |
Accumulated deficit | (1,122,440) | (1,050,804) |
Total stockholders’ equity | 437,755 | 483,939 |
Total liabilities and stockholders’ equity | $ 584,757 | $ 705,561 |